It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
We report a detailed study of a cohort of sporadic Creutzfeldt-Jakob disease (sCJD) VV1–2 type-mixed cases (valine homozygosity at codon 129 of the prion protein, PrP, gene harboring disease-related PrP, PrPD, types 1 and 2). Overall, sCJDVV1–2 subjects showed mixed clinical and histopathological features, which often correlated with the relative amounts of the corresponding PrPD type. However, type-specific phenotypic characteristics were only detected when the amount of the corresponding PrPD type exceeded 20–25%. Overall, original features of types 1 (T1) and 2 (T2) in sCJDVV1 and -VV2, including rostrocaudal relative distribution and conformational indicators, were maintained in sCJDVV1–2 except for one of the two components of T1 identified by electrophoretic mobility as T121. The T121 conformational characteristics shifted in the presence of T2, inferring a conformational effect of PrPD T2 on T121. The prevalence of sCJDVV1–2 was 23% or 57% of all sCJDVV cases, depending on whether standard or highly sensitive type-detecting procedures were adopted. This study, together with previous data from sCJDMM1–2 (methionine homozygosity at PrP gene codon 129) establishes the type-mixed sCJD variants as an important component of sCJD, which cannot be identified with current non-tissue based diagnostic tests of prion disease.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Case Western Reserve University, School of Medicine, Department of Pathology, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847); Case Western Reserve University, School of Medicine, National Prion Disease Pathology Surveillance Center, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847)
2 University of Campania “L. Vanvitelli”, Department of Advanced Medical and Surgical Sciences, Caserta, Italy (GRID:grid.67105.35)
3 University of California, Department of Psychiatry, Davis, USA (GRID:grid.27860.3b) (ISNI:0000 0004 1936 9684)
4 New York University, School of Medicine, New York, USA (GRID:grid.137628.9) (ISNI:0000 0004 1936 8753)
5 Case Western Reserve University, School of Medicine, Department of Pathology, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847)
6 Tohoku University Graduate School of Medicine, Department of Neurological Science, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943)
7 Case Western Reserve University, School of Medicine, Department of Physiology and Biophysics, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847)
8 Case Western Reserve University, School of Medicine, Department of Neurology, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847); Case Western Reserve University, School of Medicine, Department of Psychiatry, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847); Case Western Reserve University, School of Medicine, National Prion Disease Pathology Surveillance Center, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847)